Cholinergic contributions to behavioral disturbances in Alzheimer's disease

被引：4
作者：
Sunderland, T [1 ]
机构：
[1] NIMH, Geriatr Psychiat Branch, Bethesda, MD 20892 USA
来源：
INTERNATIONAL PSYCHOGERIATRICS | 2000年 / 12卷
关键词：
D O I：
10.1017/S1041610200007080
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：231 / 235
页数：5
相关论文
共 50 条
  • [31] Cholinergic strategies for Alzheimer’s disease
    J. Winkler
    Leon J. Thal
    Fred H. Gage
    Lisa J. Fisher
    Journal of Molecular Medicine, 1998, 76 : 555 - 567
  • [32] The cholinergic system in Alzheimer's disease
    Kasa, P
    Rakonczay, Z
    Gulya, K
    PROGRESS IN NEUROBIOLOGY, 1997, 52 (06) : 511 - 535
  • [33] Cholinergic strategies for Alzheimer's disease
    Winkler, J
    Thal, LJ
    Gage, FH
    Fisher, LJ
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (08): : 555 - 567
  • [34] Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease
    Garcia-Alloza, M.
    Gil-Bea, F. J.
    Diez-Ariza, M.
    Chen, C. P. L. -H.
    Francis, P. T.
    Lasheras, B.
    Ramirez, M. J.
    NEUROPSYCHOLOGIA, 2005, 43 (03) : 442 - 449
  • [35] The effects of olanzapine on Alzheimer's Disease Assessment Scale scores in patients with mild to moderate Alzheimer's disease with psychosis and behavioral disturbances
    KennedY, J
    Basson, B
    Zagar, A
    Clark, W
    Sanger, T
    Street, J
    Stauffer, V
    Bymaster, F
    Tollefson, G
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S111 - S111
  • [36] The effects of olanzapine on Alzheimer's disease assessment scale scores in patients with mild to moderate Alzheimer's disease with psychosis and behavioral disturbances
    Kennedy, JS
    Basson, B
    Clark, WS
    Sanger, TM
    Stauffer, V
    Street, JS
    Tollefson, GD
    Zagar, A
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 108S - 109S
  • [37] Letter to the editor concerning the pharmacological management of behavioral disturbances in patients with Alzheimer's disease
    Scicutella, Angela
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (18) : 2325 - 2326
  • [38] Metrifonate efficacy in the treatment of psychiatric and behavioral disturbances of Alzheimer's disease patients.
    Cummings, JL
    Cyrus, PA
    Gulanski, B
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (09) : S65 - S65
  • [39] The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
    Kishi, Taro
    Matsunaga, Shinji
    Iwata, Nakao
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 1909 - 1928
  • [40] Speech disturbances in Alzheimer's disease
    Wasilewski, Tadeusz Pawel
    Kachaniuk, Hanna
    NEUROPSYCHIATRIA I NEUROPSYCHOLOGIA, 2016, 11 (03): : 93 - 98
12345